UK Life Sciences Company Directory

Solid form sciences and API development for drug candidates

Veranova's Cambridge site is a centre of excellence in solid form and particle engineering, operating under the Pharmorphix brand. The facility provides polymorph screening, salt selection, co-crystallisation, chiral separations, and process scale-up services to pharmaceutical and biotechnology customers. Part of…

Lentiviral gene therapy developer for tumours and rare diseases

Santo Therapeutics develops in vivo lentiviral gene therapies for cancer and rare genetic disorders. Its proprietary vector platform supports programmes including ST002, an NF2 gene-replacement therapy for NF2-related schwannomatosis. The company announced the start of an investigator-initiated clinical trial of ST002…

Bioanalytical instruments and patient-derived organoid expansion services

Molecular Devices develops bioanalytical instruments, laboratory automation and cell-based research technologies for drug discovery. Its portfolio includes microplate readers, high-content imaging systems, clone screening instruments and laboratory analysis software. The company acquired Cardiff organoid specialist…

Microalgae and microbial bioactives for soil regeneration

HyveGeo is an industrial biotechnology company developing biological systems to regenerate degraded soils and support sustainable agriculture. Its circular biorefinery concept combines microalgae cultivation, microbial inoculants, compost-derived bioactives and engineered biochar. These components are used to recover…

Virus-like particle therapeutics for chronic inflammatory skin conditions

Glen Clova Scientific is a biotechnology company developing active biologic drugs for chronic inflammatory and autoimmune disorders, with an initial focus on immuno-dermatology. Its proprietary virus-like particle platform is designed to induce targeted immune responses against self-produced proteins that drive…

Lentiviral vector yield enhancement via HDAC inhibitors and producer lines

Synthistat is a biotechnology company developing technologies to increase lentiviral vector production for cell and gene therapy manufacturing. Its work combines designed histone deacetylase (HDAC) inhibitors with approaches to modify HEK293 producer cells. The company has reported early laboratory results from…

3D multi-omics platform for genetically validated drug target discovery

Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug targets for common diseases. Using patented technology integrated with a human cell type-specific multi-omics atlas, the platform links…

Fragment and structure-based drug discovery services

Vernalis (R&D) is a Cambridge-based contract drug discovery organisation specialising in fragment-based and structure-based drug discovery. The company integrates structural biology, biophysics, NMR spectroscopy, DNA-encoded library screening, medicinal chemistry, and computational approaches to identify and progress…

Targeting developmentally-silent oncogenic drivers for cancer therapy

Awen Oncology is a Welsh oncology biotechnology company developing first-in-class therapeutics that target cancer-specific proteins derived from developmental genes that are dormant in healthy adult tissue but aberrantly reactivated in tumour cells. The company's platform integrates high-throughput cell and molecular…

Contract laboratory services in genomics and histopathology

Source BioScience is a contract laboratory services group providing genomics, histopathology, and stability storage services to the pharmaceutical, biotechnology, NHS, and academic sectors. Operating through two divisions, Source Genomics delivers multi-omic sequencing services and Source LDPath provides cellular and…

DNA methylation blood tests for ovarian and pancreatic cancers

GenoME Diagnostics is a biotechnology company developing molecular blood tests for cancer detection and monitoring. Its liquid biopsy platform identifies DNA methylation and fragmentomic biomarkers, combining them into multiplexed droplet digital PCR assays. Its lead test targets ovarian cancer recurrence and…

AI-driven liquid biopsy platform for early cancer biomarker discovery

BioMavericks is an early-stage biotechnology company developing an AI-driven liquid biopsy platform for the early detection of cancer. Its lead product targets the discovery and validation of blood-based biomarkers for early-stage pancreatic cancer diagnostics, integrating molecular cell biology, multi-omics data…

AI-powered microbiome and phage therapy platform for gut disorders

GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI discovery platform integrates multi-omics and microbiome data to identify molecular disease signatures and therapeutic targets. A parallel…

Engineering biology commercialisation and biofoundry research support

SynbiCITE is an engineering biology innovation centre hosted by Imperial College London, supporting the translation of synthetic biology research into commercial applications. It connects researchers, start-ups and industry through accelerator programmes, technical expertise and access to the London Biofoundry, which…

AI-designed protein fibres as sustainable alternatives to synthetic textiles

Solena Materials is an industrial biotechnology company developing a new class of protein-based fibres for the fashion and performance apparel sectors. Using proprietary deep learning models and computational protein design, the company engineers novel proteins from first principles, which are then produced using…

High-affinity sheep monoclonal antibodies for clinical diagnostic testing

Bioventix is a UK biotechnology company that creates, manufactures and supplies high-affinity sheep monoclonal antibodies for clinical diagnostic applications, particularly where conventional antibodies have failed to detect low-concentration or difficult targets. Its antibodies are supplied to major multinational in…

Global diabetes and cardiometabolic medicines leader

Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease. The UK operation covers commercialisation, medical affairs, and clinical trial activities. Separately, Novo Nordisk Research Centre Oxford…

Veterinary ELISA diagnostic kits and immunoassay reagents

MV Diagnostics develops and supplies veterinary immunodiagnostic kits and laboratory reagents for animal disease testing. Its product portfolio includes ELISA assays, recombinant proteins and peptides used in research and veterinary diagnostic laboratories. The company develops immunoassays and multiplex testing…

Open biological data resources and bioinformatics services for life sciences

EMBL-EBI is the European Bioinformatics Institute, an intergovernmental research organisation and part of the European Molecular Biology Laboratory (EMBL). Located on the Wellcome Genome Campus in Hinxton, it maintains a suite of freely available molecular biology databases including UniProt, Ensembl, Expression Atlas…

Chromatography resins and bioseparation technologies for biomanufacturing

Astrea Bioseparations develops and manufactures chromatography resins, adsorbents, columns and nanofiber-based purification technologies for the biopharmaceutical and advanced therapeutics industries. Its portfolio supports downstream bioprocessing including affinity purification, host cell protein removal, viral…